Edit
Kuros Biosurgery AG
http://www.kuros.ch/Last activity: 18.09.2026
Active - Reference to Kuros Biosciences
Pioneering solutions for targeted and controlled bone healing. Join us in our mission to eliminate non-unions and improve patient rehabilitation.
Location: Switzerland
Total raised: $81.8M
Investors 2
| Date | Name | Website |
| - | NeoMed Man... | neomed.net... |
| 18.09.2026 | Omega Fund... | omegafunds... |
Funding Rounds 7
| Date | Series | Amount | Investors |
| 05.12.2019 | - | $12.66M | - |
| 03.08.2017 | - | $17.56M | - |
| 11.11.2015 | - | $19.82M | - |
| 18.08.2015 | - | $15.5M | - |
| 06.10.2005 | - | $4.39M | - |
| 06.06.2004 | - | $4.9M | - |
| 06.11.2002 | - | $6.97M | - |
Mentions in press and media 14
| Date | Title | Description |
| 14.08.2025 | Kuros achieves first ever operating profit in H1 | The total group revenue reached USD 63.5 million, marking a growth of 78% compared to H1 2024. The company achieved an operating profit of USD 3.5 million in the first half of 2025, marking its first positive operating result, up from an o... |
| 05.12.2019 | Kuros raises CHF12.5 million | |
| 03.08.2017 | Kuros raises CHF 17M | |
| 22.04.2016 | Kuros receives milestone payment from Checkmate | |
| 21.01.2016 | Kuros on the stock exchange | |
| 03.12.2015 | Kuros and Cytos merge | |
| 16.11.2015 | KUROS announces second closing of a CHF 20 million financing round | |
| 11.11.2015 | Kuros Biosurgery Raises Additional CHF5M in Second Close of Financing | Kuros Biosurgery AG, a Zurich, Switzerland-based biotechnology company, raised an additional CHF5m in a second closing of its financing round. The total funding raised in the round now amounts to CHF20m. The first close of the financing ann... |
| 19.08.2015 | Kuros announces closing of a CHF 15m financing round | |
| 18.08.2015 | Kuros Biosurgery Closes CHF15M Financing | Kuros Biosurgery AG, a Zurich, Switzerland-based biotechnology company developing novel biomaterials and bioactive-biomaterial combination products and focused in therapeutic areas covering sealants and orthobiologics, closed a CHF15M finan... |
Show more